Clinical Trial

Barriers and Faciliators for Physical Activity in People With RMDs

Study acronym: COPA
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2024 (before its estimated December 23, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of this project is to systematically survey and explore barriers and facilitators for the implementation of physical activity according to the physical activity recommendations of the European Alliance of Associations for Rheumatology on country specific (e.g., environmental, cultural, organization and system) level. A questionnaire to explore/identify these barriers and facilitators in the survey, will be developed through literature search, interviews with multiple stakeholders (i.e., patients with inflammatory arthritis or osteoarthritis and physical therapists) and experts in the field in four different European countries (i.e., Turkey, Switzerland, the Netherlands and France). Additionally, in Switzerland only, the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (IFAB) Questionnaire which was developed to determine the factors on personal level, will be translated into the German language. Aim is to evaluate the validity and reliability of the IFAB Questionnaire in the German-speaking population with axial Spondyloarthrits, and to perform a cultural adaptation if necessary at the same time.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06514443
Lead Sponsor Anne-Kathrin Rausch
Collaborators: Acibadem University, Leiden University Medical Center, Sorbonne University
Conditions Osteoarthritis, Knee, Osteoarthritis, Hip, Rheumatoid Arthritis, Axial Spondyloarthritis
Enrollment 400 participants
Start Date 2024-08-01
Primary Completion 2024-12-23 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-23